Burcu Önder

Baykal Selcuk, Leyla Baykal; Aksan, Burak; Kulakli, Sevgi; Oguz, Isil Deniz; Gündogdu, Mustafa; Dere, Göktürk; Onder, Sevda; Etgu, Fatma; Arica, Deniz Aksu; Oguzer, Seyda Ece; Aydemir, Burcu; Arica, Ibrahim Etem; Saral, Yunus; Yayli, Savas.

ABSTRACT

COVID infectioncan have a poor prognosis, especially in patientswith chronic diseasesand those receiving immunosuppressive or immunomodulating therapies. This study aimed to investigate the severity of COVID infectionin patientswith psoriasisand compare the infectionseverity for systemic treatmentsand comorbidities. We conducted a study in the dermatologyclinics of five different centers in the Eastern Black Searegion of Turkey. Four hundred and eighty-eight patientswere included, and % were confirmed as having COVID infection. In our study, the frequency of hospitalizationrates due to COVID infectionwere similar(%, % respectively) in patientsreceiving biological treatmentand receiving non-biologicalsystemic treatment(P=). Hospitalizationrates were higher in patientswith hypertension, androgenetic alopecia, and acitretinuse (P=, P=, P=). In conclusion, current biologictreatmentsand non-biologicsystemic treatmentsin patientswith psoriasisdid not appear to increase the riskof the severe form of COVID, except for acitretin.